Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Tetzlaff

Showing results (141-150 of 224) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling PathwayLiana Adam, F Anthony San Lucas, Richard Fowler, et al.
JCO Precision Oncology|May 7, 2019
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary MelanomasLawrence N Kwong, Mariana Petaccia De Macedo, Lauren Haydu, et al.
Journal of Cutaneous Pathology|May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinomaMario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
Transplantation|March 2, 2011
Donor-derived Strongyloides stercoralis infections in renal transplant recipientsKeith W Hamilton, Peter L Abt, Misha A Rosenbach, et al.
Journal of Cutaneous Pathology|June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesionsWei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Neuro-Oncology Advances|February 12, 2021
Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastasesGrant M Fischer, Renato A Guerrieri, Qianghua Hu, et al.
Oncoimmunology|December 7, 2017
Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumabAlexandre Reuben, Mariana Petaccia de Macedo, Jennifer McQuade, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
Cancers|June 1, 2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted TherapyShakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2016
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 CasesPriyadharsini Nagarajan, Jonathan L Curry, Jing Ning, et al.
Pageof 23

Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling PathwayLiana Adam, F Anthony San Lucas, Richard Fowler, et al.
JCO Precision Oncology|May 7, 2019
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary MelanomasLawrence N Kwong, Mariana Petaccia De Macedo, Lauren Haydu, et al.
Journal of Cutaneous Pathology|May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinomaMario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
Transplantation|March 2, 2011
Donor-derived Strongyloides stercoralis infections in renal transplant recipientsKeith W Hamilton, Peter L Abt, Misha A Rosenbach, et al.
Journal of Cutaneous Pathology|June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesionsWei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Neuro-Oncology Advances|February 12, 2021
Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastasesGrant M Fischer, Renato A Guerrieri, Qianghua Hu, et al.
Oncoimmunology|December 7, 2017
Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumabAlexandre Reuben, Mariana Petaccia de Macedo, Jennifer McQuade, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
Cancers|June 1, 2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted TherapyShakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2016
Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 CasesPriyadharsini Nagarajan, Jonathan L Curry, Jing Ning, et al.
Pageof 23